NICU Asthma Education and Secondhand Smoke Reduction Study
NCT00499915 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165
Last updated 2015-11-23
Summary
Premature infants have a significantly increased risk for developing respiratory illnesses and asthma. Secondhand smoke (SHS) also is clearly associated with increased breathing problems in children, thus exposure to smoke makes it substantially more likely for a premature infant to develop wheezing. The overall goal of this study is to test whether comprehensive asthma education combined with a home-based secondhand smoke reduction program can reduce exposure to smoke and prevent respiratory illness among premature infants. Our hypotheses are:
* More premature infants whose families receive asthma education combined with a SHS reduction intervention will live in smoke-free environments compared to infants receiving only asthma education (control group).
* Caregivers receiving the SHS reduction program will have higher rates of quit attempts and less relapse into smoking compared to caregivers in the control group.
* Infants whose families receive the combined intervention will experience less respiratory illness compared to infants in the control group.
Conditions
- Respiratory Illness
Interventions
- BEHAVIORAL
-
Secondhand Smoke Reduction and Smoking Cessation Counseling
A secondhand smoke reduction program, including smoking cessation counseling (if appropriate), and feedback about the children's cotinine levels will be implemented using principles of Motivational Interviewing.
- BEHAVIORAL
-
Asthma Education
Asthma education will be provided at NICU discharge.
Sponsors & Collaborators
-
Halcyon Hill Foundation
collaborator OTHER -
University of Rochester
lead OTHER
Principal Investigators
-
Jill S. Halterman, MD, MPH · University of Rochester
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Study of Nitric Oxide for Inhalation on Chronic Lung Disease in Premature Babies
NCT00551642 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Respiratory Pathogens in Infants
NCT01789268 ·Status: COMPLETED
-
Treatment of Persistent Wheezing in Infants and Children
NCT00301171 ·Status: COMPLETED ·Phase: NA
-
Assessing Response to Albuterol in Bronchiolitis
NCT01238445 ·Status: COMPLETED
-
Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants
NCT01748045 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Bedside Lung Ultrasound in Young Children Presenting to the Emergency Department (ED) With Wheezing
NCT01452945 ·Status: COMPLETED
-
Genetic Influences of Albuterol Response In Children With Bronchiolitis
NCT00570297 ·Status: COMPLETED
-
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
NCT00144846 ·Status: COMPLETED ·Phase: PHASE3
-
Non Invasive Evaluation of Bronchial Inflammation in Infants : a Study of the Sputum Cellularity After Hypertonic Saline Induction
NCT02245074 ·Status: TERMINATED ·Phase: NA
-
Nasal High Frequency Ventilation in Preterm Infants: A Pilot Study
NCT00296231 ·Status: COMPLETED ·Phase: PHASE1
-
Early Environmental and Maternal Determinants of Airway Inflammation in Wheezing Disorders in Infants
NCT04286464 ·Status: ENROLLING_BY_INVITATION
-
The Bronchiolitis in Hospitalized Infants Study
NCT05994183 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Early Noninvasive Positive Pressure Ventilation in Children With Status Asthmaticus
NCT01188473 ·Status: WITHDRAWN ·Phase: PHASE1
-
Non-invasive Respiratory Support in Preterm Infants
NCT03512158 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
NCT03521063 ·Status: UNKNOWN ·Phase: PHASE4
-
The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study
NCT00739115 ·Status: COMPLETED ·Phase: NA
-
Inhaled NO in Prevention of Chronic Lung Disease
NCT00000548 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
NCT01035190 ·Status: COMPLETED ·Phase: PHASE3
-
A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness
NCT03741322 ·Status: COMPLETED
-
BREATHE-Peds Pilot - I Focus Group Interviews
NCT05137223 ·Status: COMPLETED
-
Inhaled Budesonide for Non-ventilated Infants at High Risk of Bronchopulmonary Dysplasia: the i-BUD Pilot Study
NCT01895075 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature Infants
NCT00146497 ·Status: TERMINATED ·Phase: PHASE4
-
THE EFFECT OF NEBULIZED AZITHROMYCIN AS THERAPY FOR BRONCHOPULMONARY DYSPLASIA
NCT06584474 ·Status: COMPLETED ·Phase: PHASE4
-
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
NCT05285345 ·Status: RECRUITING
-
A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
NCT04264156 ·Status: TERMINATED ·Phase: PHASE2